Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) SHZ
10.98
-0.1(-0.90%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
10.98
-0.1(-0.90%)
Currency In CNY
| Market Cap | 17.3B |
| Enterprise Value | 18.06B |
| P/E Ratio | 46.1 |
| PEG Ratio | -0.99 |
| Price/Sales Ratio | 2.5 |
| Price/Book Ratio | 1.34 |
| Enterprise/Revenue | 2.64 |
| Enterprise/EBITDA | 17.08 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.06 |
| Operating Margin | 0.12 |
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
| Revenue | 5.48B |
| Revenue/Share | 3.73 |
| Gross Profit | 1.74B |
| EBITDA | 846.59M |
| Net Income | 349.49M |
| Diluted EPS | 0.24 |
| Total Cash | 2.83B |
| Total Cash/Share | 1.93 |
| Total Debt | 2.11B |
| Total Debt/Equity | 0.18 |
| Current Ratio | 2.31 |
| Book Value Per Share | 8.23 |
| 52-Week Change | -0.27 |
| 52-Week High | 14.34 |
| 52-Week Low | 10.3 |
| Moving Average 50 Days | 11.48 |
| Moving Average 200 Days | 12.15 |
| Average Volume | 4.28M |
| Shares Outstanding | 1.25B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 2.28 |
| Payout Ratio | 0.16 |
| Last Split Factor | 8:5 |
| Last Split Date | June 13, 2016 |